Brought to you by 
Incyte, Affymetrix cross-license IP, settle patent litigation
01 Jul 2002
Executive Summary
In a move that settles infringement litigation between the two genomics companies, Incyte Genomics and Affymetrix have agreed to nonexclusive, royalty-bearing cross-licensing--and an internal use license--of their respective genomics portfolios.
Deal Industry
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Alliance
- Includes Contract
- Product or Technology Swap
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Incyte, Affymetrix cross-license IP, settle patent litigation
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice